Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in Norway: A ten-year national survey

Acta Oncologica

Volumn 43, Issue 6, 2004, Pages 520-529

  Haldorsen, Ingfrid Salvesen ^a   Aarseth, Jan Harald ^a   Hollender, Aase ^b   Larsen, John Ludvig ^a   Espeland, Ansgar ^a   Mella, Olav ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FOLIC ACID; MESNA; METHOTREXATE; PREDNISONE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; BRAIN RADIATION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIAGNOSTIC IMAGING; DRUG MEGADOSE; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NEUROTOXICITY; NORWAY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RASH; RECURRENT DISEASE; REGRESSION ANALYSIS; REVIEW; SCHOOL CHILD; SEPTICEMIA; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; FEMALE; HUMANS; INCIDENCE; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NORWAY; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 4844229913     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860410015640     Document Type: Review

References (32)

1. Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 2002; 95: 1504-10.
2. Corn BW, Marcus SM, Topham A, et al. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 1997; 79: 2409-13.
3. Lutz JM, Coleman MP. Trends in primary cerebral lymphoma. Br J Cancer 1994; 70: 716-8.
4. Van der Sanden GA, Scheuten LJ, van Dijck JA, et al. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands. Cancer 2002; 94: 1548-56.
5. Hao D, DiFrancesco LM, Brasher PM, et al. Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996. Ann Oncol 1999; 10: 65-70.
6. Krogh-Jensen M, D'Amore F, Jensen MK, et al. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry. Leuk Lymphoma 1995; 19: 223-33.
7. Yau YH, O'Sullivan MG, Signorini D, Ironside JW, Whittle IR. Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland. Lancet 1996; 348: 890.
8. Au WY, Chan AC, Srivastava G, et al. Incidence and pathology of primary brain lymphoma in Hong Kong Chinese patients. Leuk Lymphoma 2000; 37: 175-9.
9. Powari M, Radotra B, Das A, et al. A study of primary central nervous system lymphoma in northern India. Surg Neurol 2002; 57: 113-6.
10. Herrlinger U, Schabet M, Bitzer M, et al. Primary central nervous system lymphoma: from clinical presentation to diagnosis. J Neurooncol 1999; 43: 219-26.
11. Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000; 92: 261-6.
12. Schlegel U, Schmidt-Wolf IG, Deckert M. Primary CNS lymphoma-Clinical presentation, pathological classification, molecular pathogenesis and treatment. J Neurol Sci 2000; 181: 1-12.
13. Henry JM, Heffner RR, Jr., Dillard SH, et al. Primary malignant lymphomas of the central nervous system. Cancer 1974; 34: 1293-302.
14. Weller M. Glucocorticoid treatment of primary CNS lymphoma. J Neurooncol 1999; 43: 237-9.
15. Nelson DF. Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL). J Neurooncol 1999; 43: 241-7.
16. Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998; 16: 859-63.
17. Ferreri AJ, Reni M, Villa E. Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann Oncol 2000; 11: 927-37.
18. Herrlinger U, Schabet M, Brugger W, et al. Primary central nervous system lymphoma 1991-1997 - Outcome and late adverse effects after combined modality treatment. Cancer 2001; 91: 130-5.
19. Ferreri AJ, Blay JY, Reni M, et al. Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J Clin Oncol 2003; 21: 266-72.
20. Ferreri AJ, Abrey LE, Blay JY, et al. Summary statement on primary central nervous system lymphomas from the Eighth International Conference on Malignant Lymphoma, Lugano, Switzerland, 12 to 15 June 2002. J Clin Oncol 2003; 21: 2407-14.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
22. Cox DR. Regression models and life tables. J Roy Statist Soc 1972; 34: 187-220.
23. Grambsch P, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-26.
24. Krogh-Jensen M, D'Amore F, Jensen MK, et al. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Ann Oncol 1994; 5: 349-54.
25. O'Neill BP, Dinapoli RP, Kurtin PJ, et al. Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?. J Neurooncol 1995; 25: 67-71.
26. Herrlinger U. Primary CNS lymphoma: findings outside the brain. J Neurooncol 1999; 43: 227-30.
27. Schabet M. Epidemiology of primary CNS lymphoma. J Neurooncol 1999; 43: 199-201.
28. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer 1994; 74: 1383-97.
29. Hayakawa T, Takakura K, Abe H, et al. Primary central nervous system lymphoma in Japan - A retrospective, cooperative study by CNS-Lymphoma Study Group in Japan. J Neurooncol 1994; 19: 197-215.
30. Hochberg FH, Miller DC. Primary central nervous system lymphoma. J Neurosurg 1988; 68: 835-53.
31. Kim DG, Nam DH, Jung HW, et al. Primary central nervous system lymphoma: variety of clinical manifestations and survival. Acta Neurochir (Wien) 1996; 138: 280-9.
32. Watne K, Scott H, Hager B, et al. Primary malignant lymphoma of the brain. A report of 24 cases from the Norwegian Radium Hospital. Acta Oncol 1992; 31: 545-50.